Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guy Pratt

Showing results (71-80 of 134) with videos related to

Pageof 14
Sort By:
British Journal of Haematology|January 8, 2025
Diagnosis and management of monoclonal gammopathy of renal significance: A British Society for Haematology good practice paperJennifer Pinney, Candice Roufosse, Andreas Kousios, et al.
Blood|July 19, 2008
Selective accumulation of virus-specific CD8+ T cells with unique homing phenotype within the human bone marrowUmaimainthan Palendira, Rosanna Chinn, Wajid Raza, et al.
Haematologica|September 22, 2011
ATM germline heterozygosity does not play a role in chronic lymphocytic leukemia initiation but influences rapid disease progression through loss of the remaining ATM alleleAnna Skowronska, Belinda Austen, Judith E Powell, et al.
Leukemia|February 27, 2024
Long-term outcomes by bone marrow B-cell depletion from the R2W trial of bortezomib with cyclophosphamide and rituximab in Waldenstrőm macroglobulinaemiaRuth de Tute, Nicholas Counsell, Laura Clifton-Hadley, et al.
Blood|November 14, 2015
ATR inhibition induces synthetic lethality and overcomes chemoresistance in TP53- or ATM-defective chronic lymphocytic leukemia cellsMarwan Kwok, Nicholas Davies, Angelo Agathanggelou, et al.
Oncotarget|May 13, 2017
Dynamic changes in clonal cytogenetic architecture during progression of chronic lymphocytic leukemia in patients and patient-derived murine xenograftsNicholas J Davies, Marwan Kwok, Clive Gould, et al.
Frontiers in Immunology|January 11, 2020
Long-Term Ibrutinib Therapy Reverses CD8<sup>+</sup> T Cell Exhaustion in B Cell Chronic Lymphocytic LeukaemiaHelen M Parry, Nikhil Mirajkar, Natasha Cutmore, et al.
European Journal of Haematology|February 20, 2022
Investigating the utility of saliva immunoglobulins for the detection of myeloma and using myeloma proteins to clarify partition between oral and systemic immunityJennifer L J Heaney, Sian Faustini, Lili Evans, et al.
Blood|February 25, 2015
Arginine dependence of acute myeloid leukemia blast proliferation: a novel therapeutic targetFrancis Mussai, Sharon Egan, Joseph Higginbotham-Jones, et al.
Cancers|July 14, 2023
Presenting Symptoms in Newly Diagnosed Myeloma, Relation to Organ Damage, and Implications for Symptom-Directed Screening: A Secondary Analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) TrialStella Bowcock, Catherine Atkin, Gulnaz Iqbal, et al.
Pageof 14

Showing results (71-80 of 134) with videos related to

Sort By:
Pageof 14
British Journal of Haematology|January 8, 2025
Diagnosis and management of monoclonal gammopathy of renal significance: A British Society for Haematology good practice paperJennifer Pinney, Candice Roufosse, Andreas Kousios, et al.
Blood|July 19, 2008
Selective accumulation of virus-specific CD8+ T cells with unique homing phenotype within the human bone marrowUmaimainthan Palendira, Rosanna Chinn, Wajid Raza, et al.
Haematologica|September 22, 2011
ATM germline heterozygosity does not play a role in chronic lymphocytic leukemia initiation but influences rapid disease progression through loss of the remaining ATM alleleAnna Skowronska, Belinda Austen, Judith E Powell, et al.
Leukemia|February 27, 2024
Long-term outcomes by bone marrow B-cell depletion from the R2W trial of bortezomib with cyclophosphamide and rituximab in Waldenstrőm macroglobulinaemiaRuth de Tute, Nicholas Counsell, Laura Clifton-Hadley, et al.
Blood|November 14, 2015
ATR inhibition induces synthetic lethality and overcomes chemoresistance in TP53- or ATM-defective chronic lymphocytic leukemia cellsMarwan Kwok, Nicholas Davies, Angelo Agathanggelou, et al.
Oncotarget|May 13, 2017
Dynamic changes in clonal cytogenetic architecture during progression of chronic lymphocytic leukemia in patients and patient-derived murine xenograftsNicholas J Davies, Marwan Kwok, Clive Gould, et al.
Frontiers in Immunology|January 11, 2020
Long-Term Ibrutinib Therapy Reverses CD8<sup>+</sup> T Cell Exhaustion in B Cell Chronic Lymphocytic LeukaemiaHelen M Parry, Nikhil Mirajkar, Natasha Cutmore, et al.
European Journal of Haematology|February 20, 2022
Investigating the utility of saliva immunoglobulins for the detection of myeloma and using myeloma proteins to clarify partition between oral and systemic immunityJennifer L J Heaney, Sian Faustini, Lili Evans, et al.
Blood|February 25, 2015
Arginine dependence of acute myeloid leukemia blast proliferation: a novel therapeutic targetFrancis Mussai, Sharon Egan, Joseph Higginbotham-Jones, et al.
Cancers|July 14, 2023
Presenting Symptoms in Newly Diagnosed Myeloma, Relation to Organ Damage, and Implications for Symptom-Directed Screening: A Secondary Analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) TrialStella Bowcock, Catherine Atkin, Gulnaz Iqbal, et al.
Pageof 14